Home
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.
Latest Actos Articles
Popular Actos Articles
Highly Recommended Actos Articles
ID Genetic Markers That Could Improve Effectiveness of Diabetes Therapies
The researchers’ findings, which were presented earlier this month in New Orleans during the ADA’s 69th Scientific Sessions, may lead to the use of individuals’ distinct genetic markers to identify which drugs will work best to treat their diabetes—allowing for truly customized, individualized medicine.
Scientists have identified five genetic biomarkers that predict how well a type 2 patient will respond to the drug Actos. Their work could be the first step toward a system that would allow doctors to predetermine which drugs will best help each person with diabetes.
Actos, manufactured by Takeda Pharmaceutical Company Ltd., is a thiazolidinedione, a drug that improves insulin sensitivity while decreasing the quantity of glucose and glycated hemoglobin (hemoglobin that has glucose and other sugars bound to it) in the bloodstream.
The scientists, from the University of Southern California's Keck School of Medicine and the Translational Genomics Research Institute in Phoenix, found the five biomarkers as they were investigating why up to 40 percent of patients treated with Actos fail to respond with improvement in their insulin sensitivity.
The researchers' findings, which were presented earlier this month in New Orleans during the 69th Scientific Sessions of the American Diabetes Association, may eventually lead to the use of individuals' distinct genetic markers to identify which drugs will work best to treat their diabetes-allowing for truly customized, individualized medicine. The findings may also encourage researchers to map other genetic markers that could lead to the design of more effective diabetes drugs. Finally, the research provides a greater understanding of how thiazolidinediones work, giving deeper insights into the mechanism of insulin sensitivity.
Categories: Actos, Diabetes, Diabetes, Insulin, Medications Research, Research, Type 2 Issues
You May Also Be Interested In...
Click Here To View Or Post Comments
0 comments -
Jul 3, 2009
-
Diabetes Health
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.
-
Topics
- Diabetic / Diabetes Health
- Type 1 / 1.5 Diabetes
- Type 2 Diabetes
- Blood Glucose / Sugar
- High/Low Blood Sugar / Fast Acting Glucose
- Insulin- Pumps, Pens & Syringes
- Continuous Glucose Monitors, CGM, Infusion Sets
- Type 2 Medications
- Hyperglycemia
- Hypoglycemia
Email to a Friend
Send a link to this page to your friends and colleagues.